AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Letrablu 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Bluewaterresearch

Salt Composition

Letrozole (2.5mg)

Overview Letrablu 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Letrablu 2.5mg Tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. In advanced cases, it aids in preventing cancerous spread. Letrablu 2.5mg Tablets may be consumed with or without food, always adhering to your physician's prescribed dosage and duration for optimal results. Dosage frequency is tailored to individual needs and determined by your doctor to manage your condition effectively. Continuous use, as directed, is crucial. Common side effects include increased perspiration, fatigue, hot flushes, and elevated cholesterol. Report any concerning side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you are currently using, as interactions may affect Letrablu's efficacy. Disclose any pregnancy or breastfeeding status for appropriate medical guidance. Your doctor might order blood tests to assess vitamin D levels and bone density before and throughout the treatment course.

Primary Ingredients of Letrablu 2.5mg Tablet

The provided text is "undefined," offering no content to rephrase.

Uses of Letrablu 2.5mg Tablet

Managing breast cancer

Major Benefits of Letrablu 2.5mg Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Letrablu 2.5mg tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Letrablu 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letrablu 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 2.5mg Letrablu tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.

How Letrablu 2.5mg Tablet works:

Estrogen production is reduced by Letrablu 2.5mg tablets, an aromatase inhibitor. This reduction in estrogen levels can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Letrablu 2.5mg Tablet and alcohol consumption.

PregnancyPregnancyUNSAFE

The use of Letrablu 2.5mg Tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in animal models and human studies has revealed substantial adverse effects on fetal development.

Breast feedingBreast feedingUNSAFE

Lactation and Letrablu 2.5mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingUNSAFE

Taking a 2.5mg Letrablu tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

For individuals with kidney disease, Letrablu 2.5mg Tablets are considered safe, and no dosage modification is typically advised. Nevertheless, data regarding its use in patients with end-stage renal failure is scarce. Physician consultation is recommended.

LiverLiverCAUTION

Patients with hepatic impairment should use Letrablu 2.5mg Tablets cautiously, potentially requiring dose modification. Physician consultation is advised.

What if you forget to take Letrablu 2.5mg Tablet :

Should you forget a Letrablu 2.5mg Tablet dose, take it promptly. However, near the time for your next dose, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Letrablu 2.5mg Tablet

LabelValue
Chemical Type Diphenylmethane derivative
Developing Habits No.
Type of Therapy Cancer Treatments

FAQs on Letrablu 2.5mg Tablet

Letrablu 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Letrablu 2.5mg tablets are anti-estrogens. They work by inhibiting aromatase, the enzyme that produces estrogen. This lowers estrogen levels, which can help prevent the growth of estrogen-dependent breast cancers.
For advanced breast cancer or cancer that has spread, continue Letrablu 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Letrablu 2.5mg Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential regimen of two years of Letrablu 2.5mg Tablet followed by three years of tamoxifen may be used.
Irbesartan and Letrablu 2.5mg Tablet can be taken together, but monitor your blood pressure closely as Letrablu 2.5mg Tablet may elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letrablu 2.5mg Tablets may cause cataracts. Report blurred vision or eye irritation to your doctor promptly.
Experiencing hot flushes may indicate a common side effect of Letrablu 2.5mg Tablet, linked to reduced estrogen levels. While these usually lessen as your body adapts, some individuals may experience them throughout treatment, subsiding a few months afterward. If bothersome, consult your doctor for management options.
While rare, Letrablu 2.5mg Tablet may cause serious side effects such as stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Letrablu 2.5mg Tablets can weaken bones (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density before, during, and after treatment to check for this.
The Ministry of Health and Family Welfare restricts Letrablu 2.5mg Tablets to use only for inducing ovulation in women with anovulatory infertility.
Letrablu 2.5mg Tablet
167